TRIM21 Orchestrates Inflammasome Assembly and Drives Autoinflammatory Pathology 2300561

Abstract Introduction Inflammasomes are pivotal cytoplasmic scaffolds that drive the maturation of interleukin (IL)-1β and IL-18 and initiate pyroptotic cell death. Tight regulation of inflammasome activity is critical, as uncontrolled IL-1β release underlies chronic inflammation and autoinflammatory disease. The adaptor protein ASC is essential for inflammasome assembly, and its polymerization and extracellular release amplify inflammatory responses. TRIM21, an E3 ubiquitin ligase and common autoantigen in autoimmune diseases, has been implicated in pyroptosis regulation; however, its role in inflammasome assembly and autoinflammatory disease remains unclear. Mechanistic insights into ASC polymerization and particle release are also incomplete. Methods We investigated TRIM21’s role in inflammasome activation using TRIM21-deficient human monocytes and bone marrow—derived macrophages from conditional Trim21 knockout mice. Systemic autoinflammation was assessed in murine models of cryopyrin-associated periodic syndrome (CAPS) and familial Mediterranean fever (FMF), and findings were validated in plasma from CAPS patients. Results TRIM21 is a conserved and essential mediator of inflammasome assembly. It interacts with, ubiquitinates, and promotes polymerization of ASC, facilitating inflammasome assembly and the release of ASC/TRIM21 particles during pyroptosis in human and mouse macrophages. Notably, systemic ASC/TRIM21 particles and corresponding autoantibodies were detected in both murine and human autoinflammatory disease. Conclusion Our findings establish TRIM21 as a critical regulator of inflammasome assembly and particle release, linking it to the pathogenesis of autoinflammatory disease. These results extend TRIM21’s known role in autoimmunity to a previously unrecognized function in driving inflammasome-mediated inflammation, highlighting it as a potential therapeutic target in autoinflammatory disorders. Funding Source n/a Topic Categories Innate Immune Responses and Host Defense: Molecular Mechanisms (INM)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.1215
Primary Topic
Inflammasome and immune disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TRIM21 Orchestrates Inflammasome Assembly and Drives Autoinflammatory Pathology 2300561

Janset Onyuru, Christian Stehlik, Sana Ismaeel, E. Jaeger et al.
The Journal of Immunology
Inflammasome and immune disorders
article

TRIM21 Orchestrates Inflammasome Assembly and Drives Autoinflammatory Pathology 2300561

Janset Onyuru, Christian Stehlik, Sana Ismaeel, E. Jaeger, Jessica Carrière, Andrea Dorfleutner, Sonal Khare, Lan Chu, Daniel Kastner, Chawon Yun, Jae Jin Chae, Vinícius Dantas Martins, Savita Devi, Hal Hoffman, Huyen Nguyen, Lucia de Almeida, Justin Ruiz, Hemisha Khatri, Kaiden Sims
article en

Abstract

Abstract Introduction Inflammasomes are pivotal cytoplasmic scaffolds that drive the maturation of interleukin (IL)-1β and IL-18 and initiate pyroptotic cell death. Tight regulation of inflammasome activity is critical, as uncontrolled IL-1β release underlies chronic inflammation and autoinflammatory disease. The adaptor protein ASC is essential for inflammasome assembly, and its polymerization and extracellular release amplify inflammatory responses. TRIM21, an E3 ubiquitin ligase and common autoantigen in autoimmune diseases, has been implicated in pyroptosis regulation; however, its role in inflammasome assembly and autoinflammatory disease remains unclear. Mechanistic insights into ASC polymerization and particle release are also incomplete. Methods We investigated TRIM21’s role in inflammasome activation using TRIM21-deficient human monocytes and bone marrow—derived macrophages from conditional Trim21 knockout mice. Systemic autoinflammation was assessed in murine models of cryopyrin-associated periodic syndrome (CAPS) and familial Mediterranean fever (FMF), and findings were validated in plasma from CAPS patients. Results TRIM21 is a conserved and essential mediator of inflammasome assembly. It interacts with, ubiquitinates, and promotes polymerization of ASC, facilitating inflammasome assembly and the release of ASC/TRIM21 particles during pyroptosis in human and mouse macrophages. Notably, systemic ASC/TRIM21 particles and corresponding autoantibodies were detected in both murine and human autoinflammatory disease. Conclusion Our findings establish TRIM21 as a critical regulator of inflammasome assembly and particle release, linking it to the pathogenesis of autoinflammatory disease. These results extend TRIM21’s known role in autoimmunity to a previously unrecognized function in driving inflammasome-mediated inflammation, highlighting it as a potential therapeutic target in autoinflammatory disorders. Funding Source n/a Topic Categories Innate Immune Responses and Host Defense: Molecular Mechanisms (INM)

The Journal of ImmunologyVol. 215(Supplement_1)
Cedars-Sinai Medical Center (US), Lurie Children's Hospital (US), National Institutes of Health (US), University of Miami (US), University of California San Diego (US), Northwestern University (PH), Indian Institute of Technology Hyderabad (IN)
Good health and well-being
Openalex Percentile: Top 14%
Inflammasome and immune disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.